Literature DB >> 1129251

A simple method for long-term drug infusion in mice: evaluation of guanazole as a model (38488).

M A Paul, C Dave.   

Abstract

A simplified technique for iv infusion in unrestricted DBA/2-J inbred mice has been described. The method, which involves direct cannulation of the tail vein with polyethylene tubing, is suitable for routine use. Guanazole, an antileukemic agent with a short plasma half-life, was evaluated as a model compound. After administration for 47 hr at the rate of 0.3 ml/hr, guanazole (30 mg/ml) caused a marked inhibition of incorporation of 14 C-uridine, administered 15 min before sacrifice, primarily into DNA of spleen, thymus and bone marrow in decreasing order. Inhibition of incorporation into RNA was less marked but followed a similar pattern. The effects on the incorporation of uridine in nucleic acids of kidney, heart and brain were minimal. Increased incorporations into RNA and DNA occurred in liver. The data for the hemopoietic and lymphoid organs, namely spleen, thymus and marrow, are consistent with the reported immunosuppressive and mylelosuppressive effects of the drug and also with the inhibition of ribonucleoside diphosphate reducaste by guanazole.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1129251     DOI: 10.3181/00379727-148-38488

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  2 in total

1.  Minimally Invasive Monitoring of Chronic Central Venous Catheter Patency in Mice Using Digital Subtraction Angiography (DSA).

Authors:  Giovanna Figueiredo; Teresa Fiebig; Stefanie Kirschner; Omid Nikoubashman; Lisa Kabelitz; Ahmed Othman; Andrea Nonn; Martin Kramer; Marc A Brockmann
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

2.  Effect of acute and chronic misonidazole administration on peripheral-nerve electrophysiology in mice.

Authors:  P J Conroy; R Von Burg; D P Penney; W Passalacqua; R M Sutherland
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.